Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2002) | Total Docs. (3years) | Total Refs. (2002) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2002) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Reviews of Physiology Biochemistry and Pharmacology | journal | 2.628 Q1 | 70 | 6 | 44 | 2012 | 229 | 44 | 5.62 | 335.33 |  |
| 2 | Pharmacological Reviews | journal | 12.251 Q1 | 254 | 23 | 64 | 6417 | 1857 | 63 | 27.44 | 279.00 |  |
| 3 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.976 Q1 | 82 | 15 | 42 | 2544 | 155 | 41 | 2.47 | 169.60 | |
| 4 | Progress in Medicinal Chemistry | journal | 1.175 Q1 | 38 | 11 | 21 | 1722 | 70 | 13 | 2.93 | 156.55 |  |
| 5 | Current Cancer Drug Targets | journal | 0.495 Q2 | 103 | 20 | 16 | 3075 | 24 | 16 | 1.50 | 153.75 |  |
| 6 | Current Drug Metabolism | journal | 1.041 Q1 | 122 | 39 | 48 | 5619 | 144 | 45 | 3.00 | 144.08 | |
| 7 | Pharmacology and Therapeutics | journal | 2.731 Q1 | 233 | 66 | 203 | 9004 | 1437 | 200 | 6.15 | 136.42 | |
| 8 | Medicinal Research Reviews | journal | 1.869 Q1 | 150 | 26 | 84 | 3534 | 481 | 83 | 6.92 | 135.92 | |
| 9 | CNS and Neurological Disorders - Drug Targets | journal | 96 | 43 | 0 | 5827 | 0 | 0 | 0.00 | 135.51 | | |
| 10 | Annual Review of Pharmacology and Toxicology | journal | 10.266 Q1 | 224 | 23 | 78 | 2986 | 1814 | 77 | 20.70 | 129.83 | |
| 11 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.502 Q2 | 108 | 39 | 18 | 5020 | 22 | 18 | 1.22 | 128.72 | |
| 12 | Current Drug Targets: Inflammation and Allergy | journal | 53 | 26 | 0 | 3033 | 0 | 0 | 0.00 | 116.65 | | |
| 13 | Current Medicinal Chemistry | journal | 2.023 Q1 | 202 | 147 | 263 | 15518 | 1518 | 241 | 4.99 | 105.56 | |
| 14 | Current Drug Targets | journal | 1.182 Q1 | 119 | 40 | 50 | 4034 | 145 | 46 | 2.90 | 100.85 | |
| 15 | Current Pharmaceutical Design | journal | 1.127 Q1 | 183 | 198 | 303 | 19253 | 1078 | 259 | 3.30 | 97.24 | |
| 16 | Expert Opinion on Emerging Drugs | journal | 0.270 Q3 | 54 | 25 | 68 | 2413 | 70 | 65 | 1.13 | 96.52 |  |
| 17 | Expert Opinion on Therapeutic Targets | journal | 0.474 Q2 | 106 | 54 | 131 | 5107 | 108 | 131 | 1.04 | 94.57 | |
| 18 | Receptors and Channels | journal | 0.726 Q2 | 44 | 31 | 61 | 2887 | 82 | 59 | 1.03 | 93.13 | |
| 19 | Infectious Disorders - Drug Targets | journal | 0.284 Q3 | 61 | 30 | 27 | 2772 | 21 | 27 | 0.78 | 92.40 | |
| 20 | Expert Opinion on Investigational Drugs | journal | 0.790 Q1 | 117 | 134 | 790 | 12336 | 1907 | 769 | 2.57 | 92.06 | |
| 21 | Cellular and Molecular Life Sciences | journal | 3.180 Q1 | 261 | 196 | 592 | 18002 | 3218 | 573 | 5.21 | 91.85 |  |
| 22 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.116 Q4 | 45 | 11 | 8 | 951 | 2 | 8 | 0.25 | 86.45 | |
| 23 | Annual Report of Shionogi Research Laboratory | journal | 0.104 Q4 | 2 | 1 | 5 | 86 | 1 | 5 | 0.33 | 86.00 |  |
| 24 | Clinical Pharmacokinetics | journal | 1.347 Q1 | 184 | 93 | 224 | 7889 | 1228 | 216 | 5.12 | 84.83 | |
| 25 | Drug Resistance Updates | journal | 1.060 Q1 | 132 | 24 | 141 | 2029 | 378 | 134 | 2.54 | 84.54 | |
| 26 | Mini-Reviews in Medicinal Chemistry | journal | 0.328 Q3 | 107 | 51 | 38 | 4269 | 40 | 38 | 1.05 | 83.71 | |
| 27 | BioDrugs | journal | 0.329 Q3 | 79 | 47 | 230 | 3842 | 264 | 217 | 1.44 | 81.74 | |
| 28 | Reviews in Contemporary Pharmacotherapy | journal | 0.403 Q2 | 18 | 4 | 38 | 311 | 78 | 38 | 2.09 | 77.75 | |
| 29 | Expert Opinion on Biological Therapy | journal | 0.575 Q2 | 102 | 92 | 84 | 7032 | 195 | 82 | 2.32 | 76.43 | |
| 30 | Side Effects of Drugs Annual | book series | 0.105 Q4 | 9 | 52 | 153 | 3813 | 9 | 153 | 0.07 | 73.33 | |
| 31 | Expert Opinion on Pharmacotherapy | journal | 0.423 Q2 | 93 | 160 | 273 | 11187 | 453 | 263 | 1.70 | 69.92 | |
| 32 | CNS Drug Reviews | journal | 0.320 Q3 | 64 | 26 | 94 | 1806 | 91 | 94 | 1.50 | 69.46 | |
| 33 | American Journal of Respiratory Medicine | journal | 34 | 51 | 0 | 3419 | 0 | 0 | 0.00 | 67.04 | | |
| 34 | Molecular Diagnosis and Therapy | journal | 68 | 36 | 185 | 2299 | 305 | 167 | 1.36 | 63.86 | | |
| 35 | Prostaglandins and Other Lipid Mediators | journal | 1.028 Q1 | 86 | 75 | 171 | 4619 | 402 | 168 | 2.90 | 61.59 | |
| 36 | Adverse Drug Reaction Bulletin | journal | 0.159 Q3 | 8 | 5 | 18 | 302 | 2 | 18 | 0.17 | 60.40 | |
| 37 | Drugs of Today | journal | 0.173 Q3 | 57 | 74 | 326 | 4312 | 153 | 322 | 0.38 | 58.27 |  |
| 38 | Drug Safety | journal | 1.006 Q1 | 140 | 96 | 253 | 5584 | 1068 | 245 | 4.10 | 58.17 | |
| 39 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.330 Q3 | 25 | 19 | 61 | 1078 | 53 | 29 | 0.65 | 56.74 | |
| 40 | Apoptosis : an international journal on programmed cell death | journal | 1.285 Q1 | 128 | 58 | 157 | 3246 | 440 | 156 | 3.62 | 55.97 | |
| 41 | Expert Opinion on Therapeutic Patents | journal | 0.435 Q2 | 88 | 132 | 419 | 7336 | 516 | 416 | 1.30 | 55.58 | |
| 42 | Inflammopharmacology | journal | 0.149 Q3 | 68 | 33 | 90 | 1806 | 35 | 90 | 0.40 | 54.73 | |
| 43 | Drug News and Perspectives | journal | 0.208 Q3 | 53 | 73 | 177 | 3964 | 90 | 177 | 0.43 | 54.30 | |
| 44 | Cardiovascular Drug Reviews | journal | 0.253 Q3 | 54 | 25 | 79 | 1343 | 58 | 79 | 0.80 | 53.72 | |
| 45 | Expert Review of Vaccines | journal | 105 | 57 | 0 | 3050 | 0 | 0 | 0.00 | 53.51 | | |
| 46 | Current Opinion in Drug Discovery and Development | journal | 0.540 Q2 | 85 | 93 | 227 | 4784 | 394 | 213 | 1.97 | 51.44 | |
| 47 | International Journal of Neuropsychopharmacology | journal | 0.794 Q1 | 125 | 47 | 137 | 2392 | 305 | 131 | 2.47 | 50.89 | |
| 48 | Pharmacogenomics | journal | 1.058 Q1 | 100 | 84 | 75 | 4272 | 291 | 70 | 3.88 | 50.86 | |
| 49 | Drugs of the Future | journal | 0.355 Q2 | 46 | 87 | 269 | 4423 | 303 | 269 | 1.09 | 50.84 | |
| 50 | Current Opinion in Investigational Drugs | journal | 0.392 Q2 | 83 | 235 | 36 | 11722 | 21 | 33 | 0.58 | 49.88 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data